Henry Schein, Inc. (HSIC): Price and Financial Metrics
Henry Schein, Inc. (HSIC)
Today's Latest Price: $66.49 USD
Updated Dec 2 4:00pm
Add HSIC to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
Ranked of 143 in Medical - Devices & Equipment
See all "A" rated Strong Buy stocks
HSIC Stock Summary
- HSIC's one year PEG ratio, measuring expected growth in earnings next year relative to current common stock price is 404.15 -- higher than 91.96% of US-listed equities with positive expected earnings growth.
- Of note is the ratio of Henry Schein Inc's sales and general administrative expense to its total operating expenses; 85.7% of US stocks have a lower such ratio.
- The volatility of Henry Schein Inc's share price is greater than that of just 15.19% US stocks with at least 200 days of trading history.
- Stocks with similar financial metrics, market capitalization, and price volatility to Henry Schein Inc are AAP, JLL, MHK, FNF, and TTC.
- Visit HSIC's SEC page to see the company's official filings. To visit the company's web site, go to www.henryschein.com.
HSIC Stock Price Chart Interactive Chart >
HSIC Price/Volume Stats
| Current price | $66.49 | 52-week high | $73.99 |
| Prev. close | $64.91 | 52-week low | $41.85 |
| Day low | $64.94 | Volume | 935,500 |
| Day high | $66.59 | Avg. volume | 1,494,891 |
| 50-day MA | $62.43 | Dividend yield | N/A |
| 200-day MA | $60.14 | Market Cap | 9.49B |
Henry Schein, Inc. (HSIC) Company Bio
Henry Schein Inc. is the world's largest provider of health-care products and services to office-based dental, animal health and medical practitioners. The company was founded in 1932 and is based in Melville, New York.
HSIC Price Forecast Based on DCF Valuation
| Current Price | DCF Fair Value Target: | Forecasted Gain: |
| $66.49 | $26.25 | -59% |
We started the process of determining a valid price forecast for Henry Schein Inc with a discounted cash flow analysis -- the results of which can be found in the table below. To summarize, we found that Henry Schein Inc ranked in the 28th percentile in terms of potential gain offered. We should note, though, that the most conservative analysis suggests this stock will yield negative results -- and thus may be a potential short opportunity. The most interesting components of our discounted cash flow analysis for Henry Schein Inc ended up being:
- The company's compound free cash flow growth rate over the past 5.73 years comes in at -0.01%; that's greater than only 22.88% of US stocks we're applying DCF forecasting to.
- HSIC's estimated cost of debt, based largely on its market capitalization and its interest coverage ratio, is 2%; for context, that number is higher than 28.59% of tickers in our DCF set.
- The weighted average cost of capital for the company is 8. This value is greater than only 22.72% stocks in the Healthcare sector that generate free cash flow.
| Terminal Growth Rate in Free Cash Flow | Return Relative to Current Share Price |
| 0% | -60% |
| 1% | -59% |
| 2% | -59% |
| 3% | -59% |
| 4% | -58% |
| 5% | -58% |
Want more companies with a valuation profile/forecast similar to that of Henry Schein Inc? See IONS, BIO, PCRX, WAT, and HAPP.
Loading social stream, please wait...